Systemic inflammation in xenograft recipients precedes activation of coagulation

Dysregulation of coagulation is considered a major barrier against successful pig organ xenotransplantation in non‐human primates. Inflammation is known to promote activation of coagulation. The role of pro‐inflammatory factors as well as the relationship between inflammation and activation of coagulation in xenograft recipients is poorly understood.

[1]  W. Baldwin,et al.  Inflammation and Transplantation , 2017 .

[2]  K. Isse,et al.  Increased Soluble CD154 (CD40 Ligand) Levels in Xenograft Recipients Correlate With the Development of De Novo Anti-Pig IgG Antibodies , 2014, Transplantation.

[3]  J. Marinković,et al.  Relationship Between High-Sensitivity C-Reactive Protein and Risk Factors in Patients With Peripheral Arterial Disease—A Cross-Sectional Study , 2013, Angiology.

[4]  M. Ezzelarab,et al.  Costimulation blockade in pig artery patch xenotransplantation – a simple model to monitor the adaptive immune response in nonhuman primates , 2012, Xenotransplantation.

[5]  Karen Y. Stokes,et al.  Platelets: a critical link between inflammation and microvascular dysfunction , 2012, The Journal of physiology.

[6]  R. Bottino,et al.  Clinical xenotransplantation: the next medical revolution? , 2012, The Lancet.

[7]  T. Deerinck,et al.  Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation , 2012, Nature Communications.

[8]  W. März,et al.  Inflammation-associated graft loss in renal transplant recipients. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  A. Chu.  Tissue Factor, Blood Coagulation, and Beyond: An Overview , 2011, International journal of inflammation.

[10]  S. Robson,et al.  Controlling coagulation dysregulation in xenotransplantation , 2011, Current opinion in organ transplantation.

[11]  D. Goldstein.  Inflammation and transplantation tolerance , 2011, Seminars in Immunopathology.

[12]  D. Cooper,et al.  Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti‐nonGal IgG binding to porcine aortic endothelial cells , 2010, Journal of thrombosis and haemostasis : JTH.

[13]  D. Cooper,et al.  Recipient Tissue Factor Expression Is Associated With Consumptive Coagulopathy in Pig‐to‐Primate Kidney Xenotransplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  W. März,et al.  Inflammation in renal transplantation. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[15]  N. Bodyak,et al.  Renal and Cardiac Endothelial Heterogeneity Impact Acute Vascular Rejection in Pig‐to‐Baboon Xenotransplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  A. Akhmedov,et al.  Guggulsterone, an anti-inflammatory phytosterol, inhibits tissue factor and arterial thrombosis , 2009, Basic Research in Cardiology.

[17]  R. Pierson,et al.  The Innate Immune Response and Activation of Coagulation in α1,3-Galactosyltransferase Gene-Knockout Xenograft Recipients , 2009, Transplantation.

[18]  A. D'apice,et al.  Complement activation and coagulation in xenotransplantation , 2009, Immunology and cell biology.

[19]  T. van der Poll.  Tissue factor as an initiator of coagulation and inflammation in the lung , 2008, Critical care.

[20]  D. Cooper,et al.  Atorvastatin Down-Regulates the Primate Cellular Response to Porcine Aortic Endothelial Cells In Vitro , 2008, Transplantation.

[21]  I. Fichtner,et al.  Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis. , 2008, Oncology reports.

[22]  John D Lambris,et al.  C5a and TNF-α Up-Regulate the Expression of Tissue Factor in Intra-Alveolar Neutrophils of Patients with the Acute Respiratory Distress Syndrome1 , 2008, The Journal of Immunology.

[23]  J. Chun,et al.  Dendritic cell PAR1–S1P3 signalling couples coagulation and inflammation , 2008, Nature.

[24]  Mårten K. J. Schneider,et al.  Current cellular innate immune hurdles in pig-to-primate xenotransplantation , 2008, Current opinion in organ transplantation.

[25]  W. Fay,et al.  C-Reactive Protein Enhances Tissue Factor Expression by Vascular Smooth Muscle Cells: Mechanisms and In Vivo Significance , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[26]  J. Morrow,et al.  Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease , 2008, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[27]  F. Di Virgilio,et al.  Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor‐bearing microparticles , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  M. Jardine,et al.  Chemokine and toll‐like receptor signaling in macrophage mediated islet xenograft rejection , 2007, Xenotransplantation.

[29]  H. Tazelaar,et al.  Increased Immunosuppression, Not Anticoagulation, Extends Cardiac Xenograft Survival , 2006, Transplantation.

[30]  Jianbin Wang,et al.  CD16+ monocytes produce IL‐6, CCL2, and matrix metalloproteinase‐9 upon interaction with CX3CL1‐expressing endothelial cells , 2006, Journal of leukocyte biology.

[31]  D. Cooper,et al.  Extended coagulation profiles of healthy baboons and of baboons rejecting GT‐KO pig heart grafts , 2006, Xenotransplantation.

[32]  R. Gans,et al.  Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  F. Taylor,et al.  Sepsis and pathophysiology of anthrax in a nonhuman primate model. , 2006, The American journal of pathology.

[34]  A. Gori,et al.  Markers of hypercoagulability and inflammation predict mortality in patients with heart failure , 2006, Journal of thrombosis and haemostasis : JTH.

[35]  W. Hawthorne,et al.  Involvement of CCR5 Signaling in Macrophage Recruitment to Porcine Islet Xenografts , 2005, Transplantation.

[36]  A. Chu.  Tissue factor mediates inflammation. , 2005, Archives of biochemistry and biophysics.

[37]  K. Tracey,et al.  The "cytokine profile": a code for sepsis. , 2005, Trends in molecular medicine.

[38]  W. Bechstein,et al.  High levels of C-reactive protein after simultaneous pancreas-kidney transplantation predict pancreas graft-related complications and graft survival , 2004, Transplantation.

[39]  P. Burger,et al.  Platelets in Inflammation and Thrombosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[40]  E. Yeh,et al.  Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells , 2003, Circulation.

[41]  Steffen Jung,et al.  Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.

[42]  E. Pamer,et al.  TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. , 2003, Immunity.

[43]  W. Kuziel,et al.  The role of chemokines and their receptors in the rejection of pig islet tissue xenografts , 2003, Xenotransplantation.

[44]  S. H. A. Chen,et al.  Production of α1,3-Galactosyltransferase-Deficient Pigs , 2002, Science.

[45]  S. Blankenberg,et al.  Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. , 2002, The American journal of cardiology.

[46]  H. Jalanko,et al.  Serum C‐reactive protein in pediatric kidney and liver transplant patients , 2002, Pediatric transplantation.

[47]  Yifan Dai,et al.  Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs , 2002, Nature Biotechnology.

[48]  W. Lagrand,et al.  Localisation of C reactive protein in infarcted tissue sites of multiple organs during sepsis. , 2002, Journal of clinical pathology.

[49]  James H Morrissey,et al.  Tissue factor as a proinflammatory agent , 2002, Arthritis Research & Therapy.

[50]  B. Melchior,et al.  Different mechanisms mediate the rejection of porcine neurons and endothelial cells transplanted into the rat brain , 2001, Xenotransplantation.

[51]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[52]  P. Reitsma,et al.  Tissue Factor Expression during Monocyte-Macrophage Differentiation , 1997, Thrombosis and Haemostasis.

[53]  M. Gascon,et al.  The Coagulation and Fibrinolytic Responses of Baboons after In Vivo Thrombin Generation – Effect of Interleukin 6 , 1997, Thrombosis and Haemostasis.

[54]  T. van der Poll,et al.  The cytokine‐mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia , 1997, European journal of clinical investigation.

[55]  J. Elias,et al.  Human alveolar macrophage and blood monocyte interleukin-6 production. , 1990, American journal of respiratory cell and molecular biology.

[56]  B. Hazenberg,et al.  The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. , 1988, Biochemical and biophysical research communications.

[57]  A. Thomson,et al.  Generation of procoagulant activity by mononuclear phagocytes: optimisation of an in vitro assay. , 1985, Journal of immunological methods.

[58]  K. Mann,et al.  Functional prothrombinase complex assembly on isolated monocytes and lymphocytes. , 1983, The Journal of biological chemistry.

[59]  M. Mccarty.  THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD , 1947, The Journal of experimental medicine.

[60]  Thomas Francis,et al.  SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS , 1930, The Journal of experimental medicine.

[61]  D. Cooper,et al.  Regulation of human platelet aggregation by genetically modified pig endothelial cells and thrombin inhibition , 2014, Xenotransplantation.

[62]  D. Davalos,et al.  Fibrinogen as a key regulator of inflammation in disease , 2011, Seminars in Immunopathology.

[63]  S. Strukova.  Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. , 2006, Frontiers in bioscience : a journal and virtual library.

[64]  N. Matsuda,et al.  Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy. , 2006, Journal of Pharmacological Sciences.

[65]  Strukova Sm.  Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. , 2006 .

[66]  D. Sachs,et al.  Marked prolongation of porcine renal xenograft survival in baboons through the use of α1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue , 2005, Nature Medicine.

[67]  T. Starzl,et al.  Production of alpha 1,3-galactosyltransferase-deficient pigs. , 2003, Science.

[68]  Yifan Dai,et al.  Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. , 2002, Nature biotechnology.

[69]  G. Riethmüller,et al.  Procoagulant activity of activated monocytes. , 1977, Haemostasis.